Get the latest Science News and Discoveries

GLP-1 medicines semaglutide and tirzepatide reduce the risk of heart failure hospitalization and death by over 40% in patients with heart failure with preserved ejection fraction finds this new study in JAMA

None

Related news:

There's a Surprising Link Between a Key Nutrient, Obesity, And Alzheimer's Risk

AI Wildlife Videos Are Fooling Millions and Putting Real Animals at Risk

Toxic fear: New study suggests flood-driven contamination deepens climate anxiety in vulnerable communities - EurekAlert!